2001
Ocular Microbiology and Immunology Group, Abstract 18
OMIG
Main Page | 2001
Abstracts| <
Previous | Next>
Ocular
Toxicity of Povidone Iodine Eyedrops: An Experimental Study
N.M Santos, L. Barbose de Sousa, M.P. Rigueiro, D. de Freitas and
M.J. Scarpi
Deparmento de Oftalmologia da Universidade Federal de São
Paulo (UNIFESP-EPM)
Purpose:
To evaluate the ocular toxicity of povidone iodine eyedrops at a
concentration of 2.5% and 0.5% and investigate the effects on corneal
epithelial wound healing and histopathological alterations.
Methods:
Each group consisted of 20 rabbits. A central circular corneal epithelial
defect of 6.5 mm diameter was created and the povidone iodine eye
drops (2.5% and 0.5% respectively) instilled in the right eye and
distilled watter in the left eye (control) of each rabbit each hour
during three days. Biomicroscopical examinations were performed
every day, focusing on the corneaconjunctival surface and the diameter
of the lesion using fluoresceine eyedrops, photo documentation,
and a computerized image analyzer. After the third day the rabbits
were sacrificed and the excised corneas evaluated histopathologically.
Statistical evaluation was performed using Friedman, Wicoxon and
Mann-Whitney testrs.
Results:
The povidone iodine eyedrops at a concentration of 2.5% caused an
increase in the would healing time (p<0.001) and conjunctivitis
in 100% with mucous secreation in 80%, punctate keratitis in 40%,
and discrete stromal edema in 10% of the cases. The histopathological
examination showed corneal ulcers and vacuolic degeneration of the
epithelial layer in 100% as well as an inflammatory infiltrate with
eosinophils in 80% of the cases. The eyes treated with povidone
iodine eyedrops at a concentration of 0.5% and the control eyes
showed complete epithelial wound healing after 72 hours and histopathologically
normal epitheliazation. Only in one case, a discrete leucocytic
infiltrate was observed perilimbar.
Conclusions:
The ocular toxicity of povidone iodine eyedrops is concentration-dependent.
The yes of the eyedrop at a concentration of 2.5% is not adequate
for daily and repetitive use. In contrast, at a concentration of
0.5% no toxicity was observed.
OMIG
Main Page | 2001
Abstracts| <
Previous | Next>
|